Alpha Cognition Inc.

Biotechnology • Healthcare • Vancouver, BC, United States • ACOG (NCM)

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.

604 564 9244 750 West Pender Street, Vancouver, BC V6C 2T8, Canada

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year? - Yahoo Finance

Yahoo Finance • Dec 5

HC Wainwright & Co. Reiterates Alpha Cognition (ACOG) Buy Recommendation - Nasdaq

Nasdaq • Dec 19

Alpha Cognition stock falls after announcing public offering plan - Investing.com

Investing.com • Sep 30

Alpha Cognition Inc. (NASDAQ:ACOG) Short Interest Up 60.0% in December - MarketBeat

MarketBeat • Dec 28

Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update - Business Wire

Business Wire • Nov 13

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Alpha Cognition Inc. had layoffs?

No layoff events have been recorded for Alpha Cognition Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Alpha Cognition Inc. in?

Alpha Cognition Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Alpha Cognition Inc. a publicly traded company?

Yes, Alpha Cognition Inc. is publicly traded under the ticker symbol ACOG on the NCM. The company has a market capitalization of approximately $0.14 billion.

Where is Alpha Cognition Inc. headquartered?

Alpha Cognition Inc. is headquartered in Vancouver, BC, United States at 750 West Pender Street, Vancouver, BC V6C 2T8, Canada.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.